eVusheld Assessment reaL wORld effectiveness in DoD Health System

Trial Identifier:	D8850R00016
Sponsor:	AstraZeneca
NCTID::	NCT05569408
Start Date:	September 2023
Primary Completion Date:	January 2024
Study Completion Date:	January 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.